XHKG
2389
Market cap55mUSD
Oct 09, Last price
0.07HKD
1D
-2.78%
1Q
-7.89%
Jan 2017
-83.33%
IPO
-97.20%
Name
Beijing Enterprse Mdcl & Hlth Ind Gp Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People’s Republic of China. It engages in the investment and operation of general health industrial park and incubator projects; sports businesses, which includes construction and operation of stadiums for winter sports; and investment in the field of the biotechnology, pharmaceutical, medical services, and medical travel. The company also provides investment management consulting services; and engages in trading geriatric care related furniture. In addition, it is involved in medical and logistics related property development activities. The company was formerly known as Beijing Enterprises Medical and Health Industry Group Limited and changed its name to Beijing Health (Holdings) Limited in June 2021. Beijing Health (Holdings) Limited was founded in 1995 and is headquartered in Cheung Sha Wan, Hong Kong.
Key people
Joint Chief Executive Officer, Executive Director · since 2015
Jing Ming
Joint Chief Executive Officer, Executive Director · since 2015
Shanchao Gu
Executive Director · since 2014
Shiang Chi Hu
Executive Director · since 2015
Executive Director · since 2017
Executive Director · since 2017
Zheng Chun Wang
Executive Director · since 2016
Ji Ming Wan
Director - Technique Global Operation Centre; Executive Deputy General Manager of Jiangsu Golden Harbour Enterprises Limited · since 2011
Chief Financial Officer, Company Secretary · since 2015
Executive Chairman of the Board · since 2015
Robert Winslow Koepp
Independent Non-Executive Director · since 2017
Independent Non-Executive Director · since 2014
Yong Xin Wu
Independent Non-Executive Director · since 2014
Yun Zhou Zhang
Independent Non-Executive Director · since 2015
Gary Zhao
Independent Non-Executive Director · since 2016
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||